Clean Science and Technology Limited
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 188 Cr | 369 Cr | 564 Cr | 791 Cr | 224 Cr | 462 Cr | 241 Cr | 264 Cr | 243 Cr | 245 Cr | 220 Cr | 249 Cr |
| Operating expenses (approx.) | 99 Cr | 199 Cr | 299 Cr | 418 Cr | 119 Cr | 257 Cr | 137 Cr | 147 Cr | 130 Cr | 151 Cr | 138 Cr | 151 Cr |
| EBITDA | 90 Cr | 170 Cr | 265 Cr | 373 Cr | 105 Cr | 205 Cr | 104 Cr | 117 Cr | 113 Cr | 94 Cr | 82 Cr | 99 Cr |
| OPM % | 47.6% | 46.1% | 47.0% | 47.2% | 46.7% | 44.4% | 43.1% | 44.4% | 46.6% | 38.3% | 37.3% | 39.5% |
| Other income | 13 Cr | 19 Cr | 27 Cr | 41 Cr | 10 Cr | 21 Cr | 5 Cr | 12 Cr | 13 Cr | 7 Cr | 10 Cr | 3 Cr |
| Interest | 0.05 Cr | 0.30 Cr | 0.36 Cr | 0.93 Cr | 0.11 Cr | 0.15 Cr | 0.13 Cr | 0.14 Cr | 0.07 Cr | 0.07 Cr | 0.17 Cr | 0.05 Cr |
| Depreciation | 11 Cr | 22 Cr | 33 Cr | 46 Cr | 16 Cr | 33 Cr | 18 Cr | 17 Cr | 19 Cr | 19 Cr | 19 Cr | 21 Cr |
| Profit before tax | 79 Cr | 148 Cr | 231 Cr | 327 Cr | 89 Cr | 172 Cr | 85 Cr | 100 Cr | 95 Cr | 75 Cr | 63 Cr | 78 Cr |
| Tax % | 25.1% | 25.0% | 24.8% | 25.3% | 25.7% | 27.5% | 23.0% | 25.6% | 25.9% | 26.0% | 26.7% | 25.0% |
| Net profit | 59 Cr | 111 Cr | 174 Cr | 244 Cr | 66 Cr | 125 Cr | 66 Cr | 74 Cr | 70 Cr | 55 Cr | 46 Cr | 58 Cr |
| EPS (₹) | ₹5.55 | ₹10.46 | ₹16.35 | ₹22.97 | ₹6.21 | ₹11.73 | ₹6.18 | ₹6.97 | ₹6.59 | ₹5.22 | ₹4.32 | ₹5.48 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 685 Cr | 936 Cr | 791 Cr | 967 Cr | 957 Cr | Sign in for TTM |
| Operating expenses (approx.) | 355 Cr | 534 Cr | 459 Cr | 540 Cr | 569 Cr | Sign in for TTM |
| EBITDA | 330 Cr | 402 Cr | 332 Cr | 426 Cr | 388 Cr | Sign in for TTM |
| OPM % | 48.2% | 43.0% | 42.0% | 44.1% | 40.5% | Sign in for TTM |
| Other income | 30 Cr | 30 Cr | 41 Cr | 39 Cr | 33 Cr | Sign in for TTM |
| Interest | 0.15 Cr | 0.20 Cr | 0.93 Cr | 0.42 Cr | 0.35 Cr | Sign in for TTM |
| Depreciation | 25 Cr | 36 Cr | 46 Cr | 69 Cr | 78 Cr | Sign in for TTM |
| Profit before tax | 305 Cr | 396 Cr | 327 Cr | 357 Cr | 310 Cr | Sign in for TTM |
| Tax % | 25.0% | 25.4% | 25.3% | 25.9% | 25.8% | Sign in for TTM |
| Net profit | 228 Cr | 295 Cr | 244 Cr | 264 Cr | 230 Cr | Sign in for TTM |
| EPS (₹) | ₹21.51 | ₹27.79 | ₹22.97 | ₹24.88 | ₹21.61 | Sign in for TTM |
| Dividend payout % | 0.0% | 18.9% | 21.8% | 20.1% | 27.8% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 11 Cr | 11 Cr | 11 Cr | 11 Cr | 11 Cr |
| Reserves | 0.0000 Cr | 999 Cr | 1,193 Cr | 1,406 Cr | 1,573 Cr |
| Borrowings | 0.33 Cr | 0.05 Cr | — | — | — |
| Other liabilities | 156 Cr | 142 Cr | 193 Cr | 191 Cr | 199 Cr |
| Total liabilities | 925 Cr | 1,152 Cr | 1,396 Cr | 1,608 Cr | 1,783 Cr |
| Fixed assets (net) | 295 Cr | 422 Cr | 599 Cr | 711 Cr | 755 Cr |
| CWIP | 44 Cr | 20 Cr | 57 Cr | 30 Cr | 118 Cr |
| Investments | 247 Cr | 353 Cr | 339 Cr | 381 Cr | 405 Cr |
| Other assets | 513 Cr | 630 Cr | 660 Cr | 799 Cr | 828 Cr |
| Total assets | 925 Cr | 1,152 Cr | 1,396 Cr | 1,608 Cr | 1,783 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 127 Cr | 279 Cr | 237 Cr | 214 Cr | 275 Cr |
| Cash from investing | -79 Cr | -270 Cr | -186 Cr | -152 Cr | -203 Cr |
| Cash from financing | -0.15 Cr | -55 Cr | -53 Cr | -53 Cr | -64 Cr |
| Net cash flow | 49 Cr | -45 Cr | -2 Cr | 10 Cr | 8 Cr |
| Free cash flow (OCF − Capex) | -12 Cr | 96 Cr | 5 Cr | 72 Cr | 73 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 2870.9% | 36.2% | 23.8% | 25.2% | 19.6% |
| ROE % | 0.0% | 29.2% | 20.3% | 18.7% | 14.5% |
| Debtor days | 82 | 57 | 76 | — | — |
| Inventory days | 131 | 117 | 160 | 148 | 156 |
| Days payable | 152 | 87 | 140 | — | — |
| Cash conversion cycle | 61 | 87 | 95 | 148 | 156 |
| Debt / equity | 0.00 | 0.0001 | 0.00 | — | — |
| Current ratio | 3.81 | 5.46 | 4.12 | 5.14 | 5.01 |
| Net debt / EBITDA | 0.00 | -0.03 | -0.03 | -0.05 | -0.07 |
Compare with peers
Loading peers…